Patrick J Heron
CIK 1365617 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$755.09M
Companies
16
Total Filings
69
Lifetime Open-Market Net
$87.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 8,817,497 | $24.38 | $214.97M | $9.07M | 15 | 2026-06-09 |
| MBX | Director | 3,927,774 | $35.51 | $139.48M | $10.00M | 4 | 2026-06-05 |
| MIRM | Director | 464,713 | $99.34 | $46.17M | $20.35M | 18 | 2026-01-27 |
| HilleVax, Inc. (HLVX) Delisted | Director | 8,552,536 | $2.09 | $17.87M | $0 | 4 | 2025-06-25 |
| Imago BioSciences, Inc. (IMGO) Delisted | Director | — | $36.01 | — | $0 | 1 | 2021-07-19 |
| PCVX | Director | 2,309,554 | $47.46 | $109.61M | $4.00M | 3 | 2021-06-03 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 1,206,167 | $0.03 | $36.2K | $0 | 5 | 2020-07-06 |
| PASG | Director | 2,977,242 | $5.81 | $17.30M | $9.90M | 2 | 2020-03-03 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | 10%+ Owner | 1,299,953 | $2.19 | $2.85M | $21.30M | 2 | 2020-01-13 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | 10%+ Owner | 2,571,450 | $64.97 | $167.07M | $8.00M | 1 | 2019-01-22 |
| ANAB | 10%+ Owner | 3,319,224 | $56.07 | $186.11M | $0 | 2 | 2018-05-15 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | 2,668,570 | — | — | $0 | 3 | 2016-01-14 |
| COLL | Director | 1,196,834 | $34.64 | $41.46M | $1.80M | 2 | 2015-09-14 |
| GKOS | 10%+ Owner | — | $126.81 | — | $0 | 1 | 2015-06-30 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | 155,645 | $221.38 | $34.46M | $3.20M | 1 | 2015-04-22 |
| Trubion Pharmaceuticals, Inc (TRBN) Delisted | Director | 0 | — | — | $0 | 4 | 2010-10-28 |
Recent Filings · Page 4 of 7
69 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-09 | HilleVax, Inc. (HLVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | ARQT | Grant (A) | +4,375 | $0 | EDGAR |
| 2022-08-23 | HilleVax, Inc. (HLVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | ARQT | Grant (A) | +4,312 | $0 | EDGAR |
| 2021-07-19 | Imago BioSciences, Inc. (IMGO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | ARQT | Grant (A) | — | $0 | EDGAR |
| 2021-06-08 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | PCVX | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +2,852 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.